WeGene
PrivateLast Round
Series C
Jan 26, 2022
Company Overview
WeGene is a biotechnology company that provides personal genetic testing, genomic data analysis, and personalized healthcare services with a focus on East Asian populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WeGene Comparables
Compare WeGene with similar companies based on industry and business-model similarity.
WeGene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 26, 2022 | ||||
| Strategic | Jul 5, 2018 | ||||
| Series B | Jan 29, 2018 | ||||
| Series A | Sep 1, 2015 | ||||
| Angel | Aug 17, 2015 |
WeGene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| K2VC | Angel |
| Ameba Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2022
Raised Series C round
WeGene Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about WeGene's valuation, stock price, and market status.